中国小儿急救医学
中國小兒急救醫學
중국소인급구의학
CHINESE PEDIATRIC EMERGENCY MEDICINE
2010年
5期
418-420,423
,共4页
郑静%肖琴%廖霓%张宁%张国英
鄭靜%肖琴%廖霓%張寧%張國英
정정%초금%료예%장저%장국영
儿童重症监护病房%革兰阴性杆菌%痰%耐药性
兒童重癥鑑護病房%革蘭陰性桿菌%痰%耐藥性
인동중증감호병방%혁란음성간균%담%내약성
Pediatric intensive care unit%Gram negative bacilli%Sputum%Drug resistance
目的 探讨成都市儿童医院重症监护病房(PICU)痰标本分离的常见革兰阴性杆菌感染的菌群分布与耐药性变迁.方法 对2004年1月至2009年12月临床收集的合格痰标本分离出的常见革兰阴性杆菌耐药性进行回顾性分析,并比较2004至2006年、2007至2009年两个时段的菌群分布及耐药性变化.所有标本按标准微生物学方法进行定量、定性培养.连续两次培养,同一优势菌株为致病菌;并对所有鉴定所用试剂及药敏分析所用抗菌药物纸片进行质量控制.结果 6年共分离出革兰阴性杆菌598株,两个时段前5位均依次为大肠埃希菌167株(27.93%)、肺炎克雷白杆菌109株(18.23%)、阴沟肠杆菌93株(15.55%)、鲍曼不动杆菌64株(10.7%)、铜绿假单胞菌43株(7.19%).对亚胺培南、阿米卡星、哌拉西林/他唑巴坦较为敏感,而耐药率最高的药物为阿莫西林、氨苄西林、多种头孢菌素等.除铜绿假单胞菌、鲍曼不动杆菌外,未发现耐亚胺培南的革兰阴性菌株;2007至2009年肺炎克雷白杆菌及大肠埃希菌产超广谱β-内酰胺酶菌株检出率较2004至2006年明显上升.结论 与2004至2006年相比,2007至2009年本院PICU常见革兰阴性杆菌感染耐药率呈上升趋势,及时监测PICU病原菌耐药趋势变化对指导危重患儿合理用药致关重要.
目的 探討成都市兒童醫院重癥鑑護病房(PICU)痰標本分離的常見革蘭陰性桿菌感染的菌群分佈與耐藥性變遷.方法 對2004年1月至2009年12月臨床收集的閤格痰標本分離齣的常見革蘭陰性桿菌耐藥性進行迴顧性分析,併比較2004至2006年、2007至2009年兩箇時段的菌群分佈及耐藥性變化.所有標本按標準微生物學方法進行定量、定性培養.連續兩次培養,同一優勢菌株為緻病菌;併對所有鑒定所用試劑及藥敏分析所用抗菌藥物紙片進行質量控製.結果 6年共分離齣革蘭陰性桿菌598株,兩箇時段前5位均依次為大腸埃希菌167株(27.93%)、肺炎剋雷白桿菌109株(18.23%)、陰溝腸桿菌93株(15.55%)、鮑曼不動桿菌64株(10.7%)、銅綠假單胞菌43株(7.19%).對亞胺培南、阿米卡星、哌拉西林/他唑巴坦較為敏感,而耐藥率最高的藥物為阿莫西林、氨芐西林、多種頭孢菌素等.除銅綠假單胞菌、鮑曼不動桿菌外,未髮現耐亞胺培南的革蘭陰性菌株;2007至2009年肺炎剋雷白桿菌及大腸埃希菌產超廣譜β-內酰胺酶菌株檢齣率較2004至2006年明顯上升.結論 與2004至2006年相比,2007至2009年本院PICU常見革蘭陰性桿菌感染耐藥率呈上升趨勢,及時鑑測PICU病原菌耐藥趨勢變化對指導危重患兒閤理用藥緻關重要.
목적 탐토성도시인동의원중증감호병방(PICU)담표본분리적상견혁란음성간균감염적균군분포여내약성변천.방법 대2004년1월지2009년12월림상수집적합격담표본분리출적상견혁란음성간균내약성진행회고성분석,병비교2004지2006년、2007지2009년량개시단적균군분포급내약성변화.소유표본안표준미생물학방법진행정량、정성배양.련속량차배양,동일우세균주위치병균;병대소유감정소용시제급약민분석소용항균약물지편진행질량공제.결과 6년공분리출혁란음성간균598주,량개시단전5위균의차위대장애희균167주(27.93%)、폐염극뢰백간균109주(18.23%)、음구장간균93주(15.55%)、포만불동간균64주(10.7%)、동록가단포균43주(7.19%).대아알배남、아미잡성、고랍서림/타서파탄교위민감,이내약솔최고적약물위아막서림、안변서림、다충두포균소등.제동록가단포균、포만불동간균외,미발현내아알배남적혁란음성균주;2007지2009년폐염극뢰백간균급대장애희균산초엄보β-내선알매균주검출솔교2004지2006년명현상승.결론 여2004지2006년상비,2007지2009년본원PICU상견혁란음성간균감염내약솔정상승추세,급시감측PICU병원균내약추세변화대지도위중환인합리용약치관중요.
Objective To study common Gram negative bacterial pathogens and their drug resistant pattern in sputum isolates from patients in pediatric intensive care unit (PICU) of Chengdu children' s hospital. Methods Comparing to the period of 2004-2006 with 2007-2009, we retrospectively reviewed eligible sputum isolates of common Gram negative bacilli and their drug resistance pattern. All specimens were processed according to standard microbiological methods for both quantitative and qualitative cultures. Pathogen was the single predominant growth after two consecutive cultures. Strict quality control was used in all test agents and paper disk for drug resistance analysis. Results Total of 598 Gram negative bacterial isolates were identified in patients over 6 years. The first 5 bacteria respectively were Escherichia coli 167 samples(27.93%), Klebsiella pneumoniae 109 samples ( 18.23% ), Enterobacter cloacae 93 samples ( 15.55% ),Acinetobacter baumannii 64 samples ( 10. 7% ), Pseudomonas aeroginosa 43 samples (7. 19% ). They were mostly sensitive to Imipenam, Amikacin, Piperacillin/Tazobactam. Most drug resistance rate was found in Amoxicillin, Ampicillin, Cephalosporin. Apart from Pseudomonas aeroginosa and Acinetobacter Baumannii,no Gram negative bacteria was found to be resistant to Imipenam. Klebsiella pneumoniae and ESBL secreting Escherichia coli isolates were obviously increasing when compared to 3 years ago. Conclusion Comparing the period of 2004-2006, the Gram negative bacterial isolates were increasing in our PICU patients during 2007 to 2009. Close monitoring of drug resistance pattern changes in PICU would guide rational use of antibiotics in these critically ill children.